LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lv, Mingming, Xu, Pengfei, Wu, Ying, Huang, Lei, Li, Wenqu, Lv, Shanshan, Wu, Xiaowei, Zeng, Xin, Shen, Rong, Jia, Xuemei, Yin, Yongmei, Gu, Yun, Yuan, Hongyan, Xie, Hui, Fu, Ziyi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914340/
https://ncbi.nlm.nih.gov/pubmed/26910840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados